E8Q-30706-63850
3 vaccinations
5 coded responses
29 check-ins
5 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 371 / TN
- Registered
- 2021-01-02
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-02
Registered in v-safe
-
2021-01-02
Dose 1 — Moderna
- 2021-01-02
-
2021-01-03
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain, Swelling · Joint pains, Muscle or body aches, Fatigue or tiredness, Diarrhea · Be unable to do your normal daily activitiesAdult check-in
-
2021-01-03
Report sent to call center — days 1–6 daily, dose 1Be unable to do your normal daily activities1 call case(s)
- 2021-01-05
- 2021-01-07
- 2021-01-08
- 2021-01-09
-
2021-01-16
Survey response — day 14, dose 1MedDRA: Injection site rash, Rash erythematous — Feeling: GoodFree text: 1 week post injection developed a red bump at injection siteMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-01-23
-
2021-01-29
Dose 2 — Moderna
-
2021-01-30
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain · Fever · Chills, Joint pains, Muscle or body aches · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
-
2021-01-31
Survey response — days 1–6 daily, dose 2MedDRA: Tachycardia — Feeling: Fair · Site: Pain, Redness, Swelling · Chills, Joint pains, Muscle or body aches, Fatigue or tiredness, Diarrhea · Be unable to do your normal daily activitiesFree text: TachycardiaMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-02
Survey response — days 1–6 daily, dose 2MedDRA: Tachycardia — Feeling: Good · Site: Pain, RednessFree text: TachycardiaMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-02-04
- 2021-02-05
- 2021-02-14
- 2021-02-19
- 2021-02-26
- 2021-03-05
-
2021-03-12
Survey response — day 42, dose 2MedDRA: Breast tenderness, Menstruation irregular — Feeling: GoodFree text: Irregular menses, breast tendernessMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-04-30
- 2021-07-30
-
2021-10-27
Dose 3 — Moderna
-
2021-10-28
Health check-in — days 1–6 daily, dose 3Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Diarrhea, Abdominal pain · Be unable to work or attend school, Be unable to do your normal daily activitiesAdult check-in
-
2021-10-29
Survey response — days 1–6 daily, dose 3MedDRA: Hyperhidrosis — Feeling: Fair · Site: Pain · Muscle or body achesFree text: SweatingMedDRA releases: 2024-11 · check-in free text available
- 2021-10-31
- 2021-11-01
- 2021-11-03
- 2021-11-17
- 2021-11-24
- 2021-12-01
- 2021-12-10
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-02 | Moderna | |
| 2 | 2021-01-29 | Moderna | |
| 3 | 2021-10-27 | Moderna | No |
Call center
1 call center case
1 priority 2/3 (triaged and no follow up)
Free text
Release 2 — day 14, dose 1
Symptoms: 1 week post injection developed a red bump at injection site
Release 3 — days 1–6 daily, dose 2
Systemic reaction (other): Tachycardia
Systemic reaction (other): Tachycardia
Release 5 — day 42, dose 2
Symptoms: Irregular menses, breast tenderness
Release 10 — days 1–6 daily, dose 3
Systemic reaction (other): Sweating
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Breast tenderness | ✓ | ✓ | ✓ |
| SD | Injection site rash | ✓ | ✓ | ✓ |
| SD | Menstruation irregular | ✓ | ✓ | ✓ |
| SD | Rash erythematous | ✓ | ✓ | ✓ |
| SRO | Hyperhidrosis | · | · | ✓ |
| SRO | Tachycardia | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release